American society for radiation oncology (ASTRO) and American College of Radiology (ACR) practice guideline for the transperineal permanent brachytherapy of prostate cancer

International Journal of Radiation Oncology Biology Physics

Volumn 79, Issue 2, 2011, Pages 335-341

  Rosenthal, Seth A ^a   Bittner, Nathan H J ^b   Beyer, David C ^c   Demanes, D Jeffrey ^d   Goldsmith, Brian J ^a   Horwitz, Eric M ^e   Ibbott, Geoffrey S ^f   Lee, W Robert ^g   Nag, Subir ^h   Suh, W Warren ⁱ   Potters, Louis ^j  

^a Radiological Associates of Sacramento Medical Group Inc   (United States)

^b Tacoma Water   (United States)

^c Arizona Oncology Services   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e FOX CHASE CANCER CENTER   (United States)

^f UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^g DUKE UNIVERSITY MEDICAL CENTER   (United States)

^h Kaiser Permanante ^*  (United States)

ⁱ Cancer Center of Santa Barbara   (United States)

^j LONG ISLAND JEWISH MEDICAL CENTER   (United States)

more..

Author keywords

Brachytherapy; Dosimetry; Prostate Cancer; Quality Assurance; Safety

Indexed keywords

AMERICAN COLLEGE OF RADIOLOGIES; ANDROGEN SUPPRESSION; BRACHYTHERAPY; COLLABORATIVE EFFORTS; DOSIMETRIC PARAMETER; EXTERNAL BEAM RADIATION; PROSTATE BRACHYTHERAPY; PROSTATE CANCERS; RADIATION ONCOLOGISTS; RADIATION ONCOLOGY; RADIATION SAFETY; SAFETY; TREATMENT MODALITY; TREATMENT-RELATED MORBIDITIES;

DISEASES; DISTRIBUTED COMPUTER SYSTEMS; DOSIMETRY; ONCOLOGY; QUALITY ASSURANCE; QUALITY CONTROL; RADIATION; RADIOLOGY;

RADIOTHERAPY;

ANDROGEN DEPRIVATION THERAPY; ARTICLE; BRACHYTHERAPY; CANCER RADIOTHERAPY; DOSIMETRY; EXTERNAL BEAM RADIOTHERAPY; FOLLOW UP; HEALTH CARE PERSONNEL; HEALTH CARE QUALITY; HUMAN; IMAGING SYSTEM; MEDICAL DOCUMENTATION; MEDICAL SOCIETY; PATIENT SAFETY; PATIENT SELECTION; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROSTATE CANCER; RADIATION SAFETY; TREATMENT PLANNING;

ACCREDITATION; ANDROGEN ANTAGONISTS; BRACHYTHERAPY; CERTIFICATION; DIAGNOSTIC IMAGING; GUIDELINE ADHERENCE; HEALTH PHYSICS; HUMANS; MALE; PATIENT SELECTION; PROSTATIC NEOPLASMS; QUALITY CONTROL; RADIATION ONCOLOGY; RADIOTHERAPY DOSAGE; SOCIETIES, MEDICAL; TECHNOLOGY, RADIOLOGIC; UNITED STATES;

EID: 78650848667     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2010.08.045     Document Type: Article

References (71)

1. A.V. D'Amico, R. Whittington, and S.B. Malkowicz Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer Jama 280 1998 969 974 (Pubitemid 28445094)
2. P.A. Kupelian, L. Potters, and D. Khuntia Radical prostatectomy, external beam radiotherapy <72 Gy, external beam radiotherapy > or =72 Gy, permanent seed implantation, or combined seeds/external beam radiotherapy for stage T1-T2 prostate cancer Int J Radiat Oncol Biol Phys 58 2004 25 33
3. J.E. Sylvester, P.D. Grimm, and J.C. Blasko 15-Year biochemical relapse free survival in clinical Stage T1-T3 prostate cancer following combined external beam radiotherapy and brachytherapy; Seattle experience Int J Radiat Oncol Biol Phys 67 2007 57 64
4. ACR practice guideline for continuing medical education Practice Guidelines and Medical Standards 2008 American College of Radiology Reston, Va 1-2
5. D.C. Beyer, T. Thomas, and J. Hilbe Relative influence of Gleason score and pretreatment PSA in predicting survival following brachytherapy for prostate cancer Brachytherapy 2 2003 77 84
6. A.V. D'Amico, R. Whittington, and S.B. Malkowicz Pretreatment nomogram for prostate-specific antigen recurrence after radical prostatectomy or external-beam radiation therapy for clinically localized prostate cancer J Clin Oncol 17 1999 168 172
7. A.V. D'Amico, D. Schultz, and B. Silver The clinical utility of the percent of positive prostate biopsies in predicting biochemical outcome following external-beam radiation therapy for patients with clinically localized prostate cancer Int J Radiat Oncol Biol Phys 49 2001 679 684
8. G.S. Merrick, W.M. Butler, and R.W. Galbreath Relationship between percent positive biopsies and biochemical outcome after permanent interstitial brachytherapy for clinically organ-confined carcinoma of the prostate gland Int J Radiat Oncol Biol Phys 52 2002 664 673
9. Radiation Oncology/RTOG Trails/0232. http://en.wikibooks.org/wiki/ Radiation-Oncology/RTOG-Trials/0232. Accessed March 30, 2009.
10. J.M. Cosset, T. Flam, and N. Thiounn Selecting patients for exclusive permanent implant prostate brachytherapy: the experience of the Paris Institut Curie/Cochin Hospital/Necker Hospital group on 809 patients Int J Radiat Oncol Biol Phys 71 2008 1042 1048
11. S.J. Frank, P.D. Grimm, and J.E. Sylvester Interstitial implant alone or in combination with external beam radiation therapy for intermediate-risk prostate cancer: a survey of practice patterns in the United States Brachytherapy 6 2007 2 8
12. N.N. Stone, L. Potters, and B.J. Davis Multicenter analysis of effect of high biologic effective dose on biochemical failure and survival outcomes in patients with Gleason score 7-10 prostate cancer treated with permanent prostate brachytherapy Int J Radiat Oncol Biol Phys 73 2009 341 346
13. R.G. Stock, O. Cahlon, and J.A. Cesaretti Combined modality treatment in the management of high-risk prostate cancer Int J Radiat Oncol Biol Phys 59 2004 1352 1359
14. M. Bolla, L. Collette, and L. Blank Long-term results with immediate androgen suppression and external irradiation in patients with locally advanced prostate cancer (an EORTC study): a phase III randomised trial Lancet 360 2002 103 106
15. M. Bolla, J.L. Descotes, and X. Artignan Adjuvant treatment to radiation: combined hormone therapy and external radiotherapy for locally advanced prostate cancer BJU Int 100 Suppl. 2 2007 44 47
16. E.M. Horwitz, K. Bae, and G.E. Hanks Ten-year follow-up of radiation therapy oncology group protocol 92-02: a phase III trial of the duration of elective androgen deprivation in locally advanced prostate cancer J Clin Oncol 26 2008 2497 2504
17. C.A. Lawton, M. DeSilvio, and M. Roach 3rd An update of the phase III trial comparing whole pelvic to prostate only radiotherapy and neoadjuvant to adjuvant total androgen suppression: updated analysis of RTOG 94-13, with emphasis on unexpected hormone/radiation interactions Int J Radiat Oncol Biol Phys 69 2007 646 655
18. M. Roach 3rd, M. DeSilvio, and C. Lawton Phase III trial comparing whole-pelvic versus prostate-only radiotherapy and neoadjuvant versus adjuvant combined androgen suppression: Radiation Therapy Oncology Group 9413 J Clin Oncol 21 2003 1904 1911 (Pubitemid 46606377)
19. N. Bittner, G.S. Merrick, and K.E. Wallner Whole-pelvis radiotherapy in combination with interstitial brachytherapy: does coverage of the pelvic lymph nodes improve treatment outcome in high-risk prostate cancer? Int J Radiat Oncol Biol Phys 76 2010 1078 1084
20. G.S. Merrick, W.M. Butler, and K.E. Wallner Androgen deprivation therapy does not impact cause-specific or overall survival in high-risk prostate cancer managed with brachytherapy and supplemental external beam Int J Radiat Oncol Biol Phys 68 2007 34 40
21. S.M. Hastak, J. Gammelgaard, and H.H. Holm Transrectal ultrasonic volume determination of the prostate-a preoperative and postoperative study J Urol 127 1982 1115 1118
22. H.H. Holm, N. Juul, and J.F. Pedersen Transperineal 125iodine seed implantation in prostatic cancer guided by transrectal ultrasonography J Urol 130 1983 283 286
23. V. Narayana, P.L. Roberson, and A.T. Pu Impact of differences in ultrasound and computed tomography volumes on treatment planning of permanent prostate implants Int J Radiat Oncol Biol Phys 37 1997 1181 1185 (Pubitemid 27230045)
24. V. Narayana, P.L. Roberson, and R.J. Winfield Impact of ultrasound and computed tomography prostate volume registration on evaluation of permanent prostate implants Int J Radiat Oncol Biol Phys 39 1997 341 346
25. R. Nath, A.S. Meigooni, and A. Melillo Some treatment planning considerations for 103Pd and 125I permanent interstitial implants Int J Radiat Oncol Biol Phys 22 1992 1131 1138
26. J.N. Roy, K.E. Wallner, and S.T. Chiu-Tsao CT-based optimized planning for transperineal prostate implant with customized template Int J Radiat Oncol Biol Phys 21 1991 483 489
27. R.G. Stock, N.N. Stone, and M.F. Wesson A modified technique allowing interactive ultrasound-guided three-dimensional transperineal prostate implantation Int J Radiat Oncol Biol Phys 32 1995 219 225
28. E.P. Saibishkumar, J. Borg, and I. Yeung Sequential comparison of seed loss and prostate dosimetry of stranded seeds with loose seeds in 125I permanent implant for low-risk prostate cancer Int J Radiat Oncol Biol Phys 73 2009 61 68
29. R. Nath, L.L. Anderson, and G. Luxton Dosimetry of interstitial brachytherapy sources: recommendations of the AAPM Radiation Therapy Committee Task Group No. 43. American Association of Physicists in Medicine Med Phys 22 1995 209 234
30. D. Beyer, R. Nath, and W. Butler American brachytherapy society recommendations for clinical implementation of NIST-1999 standards for (103)palladium brachytherapy. The clinical research committee of the American Brachytherapy Society Int J Radiat Oncol Biol Phys 47 2000 273 275
31. W.S. Bice Jr., B.R. Prestidge, and J.J. Prete Clinical impact of implementing the recommendations of AAPM Task Group 43 on permanent prostate brachytherapy using 125I. American Association of Physicists in Medicine Int J Radiat Oncol Biol Phys 40 1998 1237 1241
32. R.G. Stock, N.N. Stone, and A. Tabert A dose-response study for I-125 prostate implants Int J Radiat Oncol Biol Phys 41 1998 101 108
33. N.N. Stone, L. Potters, and B.J. Davis Customized dose prescription for permanent prostate brachytherapy: insights from a multicenter analysis of dosimetry outcomes Int J Radiat Oncol Biol Phys 69 2007 1472 1477
34. K. Wallner, G. Merrick, and L. True 20 Gy versus 44 Gy supplemental beam radiation with Pd-103 prostate brachytherapy: preliminary biochemical outcomes from a prospective randomized multi-center trial Radiother Oncol 75 2005 307 310
35. R. Nath, L.L. Anderson, and J.A. Meli Code of practice for brachytherapy physics: report of the AAPM Radiation Therapy Committee Task Group No. 56. American Association of Physicists in Medicine Med Phys 24 1997 1557 1598
36. K. Wallner, G. Merrick, and L. True I-125 versus Pd-103 for low-risk prostate cancer: morbidity outcomes from a prospective randomized multicenter trial Cancer J 8 2002 67 73
37. W.S. Bice Point: Cesium-131: ready for prime time Brachytherapy 8 2009 1 3
38. W.S. Bice, B.R. Prestidge, and S.M. Kurtzman Recommendations for permanent prostate brachytherapy with (131)Cs: a consensus report from the Cesium Advisory Group Brachytherapy 7 2008 290 296
39. A. Sahgal, S. Jabbari, and J. Chen Comparison of dosimetric and biologic effective dose parameters for prostate and urethra using 131 Cs and 125 I for prostate permanent implant brachytherapy Int J Radiat Oncol Biol Phys 72 2008 247 254
40. G.S. Merrick, W.M. Butler, and K.E. Wallner Prophylactic versus therapeutic alpha-blockers after permanent prostate brachytherapy Urology 60 2002 650 655
41. ACR practice guideline for communication: radiation oncology Practice Guidelines and Technical Standards 2008 American College of Radiology Reston, Va 931-936
42. D.F. Dubois, B.R. Prestidge, and L.A. Hotchkiss Source localization following permanent transperineal prostate interstitial brachytherapy using magnetic resonance imaging Int J Radiat Oncol Biol Phys 39 1997 1037 1041
43. M.A. Moerland, H.K. Wijrdeman, and R. Beersma Evaluation of permanent I-125 prostate implants using radiography and magnetic resonance imaging Int J Radiat Oncol Biol Phys 37 1997 927 933
44. Y. Yu, L.L. Anderson, and Z. Li Permanent prostate seed implant brachytherapy: report of the American Association of Physicists in Medicine Task Group No. 64 Med Phys 26 1999 2054 2076
45. R. Nath, W.S. Bice, and W.M. Butler AAPM recommendations on dose prescription and reporting methods for permanent interstitial brachytherapy for prostate cancer: report of Task Group 137 Med Phys 36 2009 5310 5322
46. B.R. Prestidge, W.S. Bice, and E.J. Kiefer Timing of computed tomography-based postimplant assessment following permanent transperineal prostate brachytherapy Int J Radiat Oncol Biol Phys 40 1998 1111 1115
47. F.M. Waterman, N. Yue, and S. Reisinger Effect of edema on the post-implant dosimetry of an I-125 prostate implant: a case study Int J Radiat Oncol Biol Phys 38 1997 335 339
48. P.L. Roberson, P.W. McLaughlin, and V. Narayana Use and uncertainties of mutual information for computed tomography/ magnetic resonance (CT/MR) registration post permanent implant of the prostate Med Phys 32 2005 473 482
49. D.F. Dubois, B.R. Prestidge, and L.A. Hotchkiss Intraobserver and interobserver variability of MR imaging- and CT-derived prostate volumes after transperineal interstitial permanent prostate brachytherapy Radiology 207 1998 785 789
50. W.R. Lee, M. Roach 3rd, and J. Michalski Interobserver variability leads to significant differences in quantifiers of prostate implant adequacy Int J Radiat Oncol Biol Phys 54 2002 457 461
51. S. Nag Brachytherapy for prostate cancer: summary of American Brachytherapy Society recommendations Semin Urol Oncol 18 2000 133 136 (Pubitemid 30395863)
52. S. Nag, D. Beyer, and J. Friedland American Brachytherapy Society (ABS) recommendations for transperineal permanent brachytherapy of prostate cancer Int J Radiat Oncol Biol Phys 44 1999 789 799
53. S. Nag, W. Bice, and K. DeWyngaert The American Brachytherapy Society recommendations for permanent prostate brachytherapy postimplant dosimetric analysis Int J Radiat Oncol Biol Phys 46 2000 221 230
54. M.A. Kollmeier, R.G. Stock, and N. Stone Biochemical outcomes after prostate brachytherapy with 5-year minimal follow-up: importance of patient selection and implant quality Int J Radiat Oncol Biol Phys 57 2003 645 653
55. W.R. Lee, K. Bae, and C.A. Lawton A descriptive analysis of postimplant dosimetric parameters from Radiation Therapy Oncology Group P0019 Brachytherapy 5 2006 239 243
56. L. Potters, Y. Cao, and E. Calugaru A comprehensive review of CT-based dosimetry parameters and biochemical control in patients treated with permanent prostate brachytherapy Int J Radiat Oncol Biol Phys 50 2001 605 614
57. R.G. Stock, N.N. Stone, and J.K. DeWyngaert Prostate specific antigen findings and biopsy results following interactive ultrasound guided transperineal brachytherapy for early stage prostate carcinoma Cancer 77 1996 2386 2392
58. M.J. Zelefsky, D.A. Kuban, and L.B. Levy Multi-institutional analysis of long-term outcome for stages T1-T2 prostate cancer treated with permanent seed implantation Int J Radiat Oncol Biol Phys 67 2007 327 333
59. T. Sherertz, K. Wallner, and G. Merrick Factors predictive of rectal bleeding after 103Pd and supplemental beam radiation for prostate cancer Brachytherapy 3 2004 130 135
60. A. Tran, K. Wallner, and G. Merrick Rectal fistulas after prostate brachytherapy Int J Radiat Oncol Biol Phys 63 2005 150 154
61. G.S. Merrick, W.M. Butler, and K.E. Wallner The impact of radiation dose to the urethra on brachytherapy-related dysuria Brachytherapy 4 2005 45 50
62. M.M. Goodsitt, P.L. Carson, and S. Witt Real-time B-mode ultrasound quality control test procedures. Report of AAPM Ultrasound Task Group No. 1 Med Phys 25 1998 1385 1406
63. ACR technical standard for diagnostic medical physics performance monitoring of real time ultrasound equipment Practice Guidelines and Technical Standards 2008 American College of Radiology Reston, Va 1165-1167
64. G.J. Kutcher, L. Coia, and M. Gillin Comprehensive QA for radiation oncology: report of AAPM Radiation Therapy Committee Task Group 40 Med Phys 21 1994 581 618
65. W.M. Butler, W.S. Bice Jr., and L.A. DeWerd Third-party brachytherapy source calibrations and physicist responsibilities: report of the AAPM Low Energy Brachytherapy Source Calibration Working Group Med Phys 35 2008 3860 3865
66. ACR practice guideline for radiation oncology Practice Guidelines and Technical Standards 2008 American College of Radiology Reston, Va 931-936
67. D.A. Kuban, L.B. Levy, and L. Potters Comparison of biochemical failure definitions for permanent prostate brachytherapy Int J Radiat Oncol Biol Phys 65 2006 1487 1493
68. M. Roach 3rd, G. Hanks, and H. Thames Jr. Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: recommendations of the RTOG-ASTRO Phoenix Consensus Conference Int J Radiat Oncol Biol Phys 65 2006 965 974
69. C. Bostancic, G.S. Merrick, and W.M. Butler Isotope and patient age predict for PSA spikes after permanent prostate brachytherapy Int J Radiat Oncol Biol Phys 68 2007 1431 1437
70. W. Cavanagh, J.C. Blasko, and P.D. Grimm Transient elevation of serum prostate-specific antigen following (125)I/(103)Pd brachytherapy for localized prostate cancer Semin Urol Oncol 18 2000 160 165
71. F.A. Critz, W.H. Williams, and J.B. Benton Prostate specific antigen bounce after radioactive seed implantation followed by external beam radiation for prostate cancer J Urol 163 2000 1085 1089